Paul Austin on Microdosing and the Future of Psychedelics

Led by public figures like Michael Pollan, Tim Ferriss, and even Joe Rogan, and leading institutions like Johns Hopkins, NYU, Berkeley, and Imperial College London, therapeutic psychedelics are going mainstream again

The big picture: While research continues, psychedelic medicine could reshape the future of healthcare and wellness. As momentum builds, scientists, startups, investors, and big pharma are plotting their next move.

In a Phase II trial of patients who suffered from chronic, treatment-resistant PTSD for an average of 17 years, 56% showed no signs of the condition after one MDMA-assisted therapy session. Following up at the one-year mark, 68% no longer had PTSD.